EyePoint Pharmaceuticals
EYPT
#6800
Rank
A$0.77 B
Marketcap
$11.36
Share price
-0.28%
Change (1 day)
-65.79%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$0.13 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's total liabilities are A$0.13 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

EyePoint Pharmaceuticals - Total liabilities on balance sheet (from 2003 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.13 B5.68%
2022-12-31A$0.12 B13.27%
2021-12-31A$0.10 B14.49%
2020-12-31A$95.16 M3.08%
2019-12-31A$92.32 M
2018-06-30A$81.02 M1065.88%
2017-06-30A$6.94 M-51.65%
2016-06-30A$14.37 M22.57%
2015-06-30A$11.72 M42.57%
2014-06-30A$8.22 M-12.05%
2013-06-30A$9.35 M37.63%
2012-06-30A$6.79 M-24.93%
2011-06-30A$9.05 M-23.63%
2010-06-30A$11.85 M-29.54%
2009-06-30A$16.82 M-37.3%
2008-06-30A$26.83 M19.86%
2007-06-30A$22.38 M-62.95%
2006-06-30A$60.43 M398.92%
2005-06-30A$12.11 M521.12%
2004-06-30A$1.95 M121.34%
2003-06-30A$0.88 M
2001-06-30A$0.28 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$0.15 B 18.24%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.03 M-96.17% Bahamas